KorrekturOpen Access · CC BY 4.0
Correction to “Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration‐Resistant Prostate Cancer (mCRPC): A Phase Ib Trial”
MedComm · 2026-11 · 7 (11)
DOI: 10.1002/mco2.71023 ↗Kurz gefasst
Korrektur in der Zeitschrift MedComm, online erschienen am 01.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration‐Resistant Prostate Cancer (mCRPC): A Phase Ib Trial”. MedComm, 7(11). https://doi.org/10.1002/mco2.71023
Vancouver
Correction to “Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration‐Resistant Prostate Cancer (mCRPC): A Phase Ib Trial”. MedComm. 2026;7(11). doi:10.1002/mco2.71023
BibTeX
@article{euvimed2026,
title = {Correction to “Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration‐Resistant Prostate Cancer (mCRPC): A Phase Ib Trial”},
journal = {MedComm},
year = {2026},
volume = {7},
number = {11},
doi = {10.1002/mco2.71023}
}
EUVIMED